The European Medicines Agency has confirmed that the UK drug regulator, the MHRA, is continuing to bid for EU regulatory work, including centralized new drug application evaluations, even though the clock is ticking down to the Brexit date of March 29, 2019.
“The UK delegation is still bidding for rapporteurships for new applications for centrally authorised products in various collaborative arrangements with...